Friday, March 27, 2020 9:18:53 AM
Astrotech’s BreathTest-1000 Confirmed to Detect Lung Disease Metabolites at Parts Per Billion
AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation [NASDAQ: ASTC] announced that the BreathTest-1000™ lung disease screening device that is under development detects a known metabolite that is associated with lung diseases at very low parts per billion (ppb) concentrations. On March 25, the Company announced that it is working on developing the BreathTest-1000™ to detect volatile organic compound metabolites present in lung diseases such as the Coronavirus (“COVID-19”) and pneumonia.
“The Company just reached a milestone in its vision of providing what it believes to be a highly accurate field instrument that, subject to applicable regulatory approval, may provide lung disease testing worldwide. Today’s news is exciting because it accelerates the development process of the BreathTest-1000™ and we believe gets us closer to joining the front-line in the fight against lung diseases, such as COVID-19,” stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation.
“The Company was able to move quickly in the development of the BreathTest-1000™ because the core mass spectrometry technology it utilizes has been fully commercialized and deployed for explosives trace detection. Our goal is to satisfy all regulatory requirements for the BreathTest-1000™ as rapidly as possible once the necessary application developments are completed. We believe that few, if any, changes will need to be made to the underlying technology. We plan to devote our efforts towards developing a simple and consistent sample introduction system,” Mr. Pickens concluded.
Recent ASTC News
- Astrotech Announces Listing to the GSA as an Approved United States Government Vendor • GlobeNewswire Inc. • 04/08/2024 01:00:00 PM
- Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference • GlobeNewswire Inc. • 04/02/2024 01:00:00 PM
- Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000 • GlobeNewswire Inc. • 03/25/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:37:04 PM
- Astrotech Reports Second Quarter Of Fiscal Year 2024 Financial Results • GlobeNewswire Inc. • 02/12/2024 09:35:27 PM
- IBN Coverage Initiated for Astrotech Corp. • GlobeNewswire Inc. • 01/17/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:28:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 10:29:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 04:13:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 10:54:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 10:35:31 PM
- Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems • GlobeNewswire Inc. • 11/28/2023 02:04:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 06:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 08:58:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 04:52:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 06:34:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:42:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:37:28 PM
- Astrotech Reports First Quarter of Fiscal Year 2024 Financial Results • GlobeNewswire Inc. • 11/13/2023 09:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:04:46 PM
- 1ST DETECT SECURES SIGNIFICANT PURCHASE ORDER FOR ADDITIONAL CHECKPOINT SECURITY UNITS • GlobeNewswire Inc. • 11/13/2023 02:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/01/2023 08:43:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/01/2023 08:34:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM